Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: d. matt who wrote (2540)	2/25/1998 10:11:00 PM
From: Linda Kaplan	Respond to of 7041

D: My info was that they had $68 million in December when they announced they may spend up to $10 million on stock buy back. They would have had ordinary expenses since December, too. Perhaps my info was incorrect? Linda

To: d. matt who wrote (2540)	2/25/1998 10:12:00 PM
From: Bill Wexler	Respond to of 7041

<<when you start to make statements that are are not entirely accurate>> Wrong. My statements are 100% accurate. Zonagen's last 10-Q showed $70,000,000 in cash and equivalents. Subtract roughly $6 million for the last 3 months (and I'm being kind) - and we get $64 million. there are approx. 13 million fully-diluted shares outstanding (counting convertibles, options, etc.). Therefore we get about $5 a share in cash. I'm guessing that it will be somewhat less, but that is the high end of my estimate. . <<who do Mcgarr and Opedyke work for?>> McGarr Capital. But then again, you already knew that. When are you morons going to stop registering on SI under multiple aliases to try (and fail) to push this stock? Weren't you already embarrassed by the "Keith Rubin MD" failure?